KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for Tough-to-Treat cancer linked to HIV
Disease control OngoingThis early-stage trial is testing the safety and initial effectiveness of combining two anti-cancer drugs, pomalidomide and liposomal doxorubicin, for people with advanced or hard-to-treat Kaposi sarcoma (KS). The study involves 62 adults with KS, including those with HIV, who re…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Two-Pronged attack tested for stubborn skin cancer
Disease control TerminatedThis study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, for adults with classic Kaposi sarcoma that had come back or stopped responding to prior chemotherapy. The goal was to see if this two-drug approach could shrink tumors and control the disease bett…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Researchers track cancer response to standard drugs in HIV patients
Knowledge-focused OngoingThis study observes how HIV-related Kaposi Sarcoma, a type of cancer, responds to standard chemotherapy treatments given in Malawi and South Africa. It follows 127 adult patients already receiving standard care to understand why outcomes vary and identify markers that could predi…
Matched conditions: KAPOSI SARCOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Researchers dig into old scans to solve a Bone-Weakening puzzle
Knowledge-focused OngoingThis study aims to understand why people with HIV and certain cancers (caused by KSHV virus) often lose bone density, which increases fracture risk. Researchers will analyze existing medical records and CT scans from about 40 patients treated at the NIH between 2005 and 2020. The…
Matched conditions: KAPOSI SARCOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC